Pharnext Strengthens its Senior Leadership Team with the Appointment of Scott Johnson as VP, Head of Quality
PARIS, FRANCE / ACCESSWIRE / January 4, 2023 / Pharnext SA (FR001400BV89:ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative